Norges Bank Surmodics Inc Transaction History

Norges Bank

$772 Billion
Q2 2025

A detailed history of Norges Bank transactions in Surmodics Inc stock. As of the latest transaction made, Norges Bank holds 31,600 shares of SRDX stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,600

Holding current value

$1.2 Million

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$26.76 - $31.1 $845,616 - $982,760	31,600 New	31,600 $938,000
Q4 2024 Feb 12, 2025	BUY	$37.5 - $40.13 $1.19 Million - $1.27 Million	31,600 New	31,600 $1.25 Million
Q2 2024 Aug 14, 2024	BUY	$25.39 - $42.1 $802,324 - $1.33 Million	31,600 New	31,600 $1.33 Million
Q1 2024 May 14, 2025	BUY	$27.44 - $35.56 $867,104 - $1.12 Million	31,600 New	31,600 $927,000
Q4 2023 Feb 09, 2024	BUY	$28.47 - $38.49 $899,652 - $1.22 Million	31,600 New	31,600 $1.15 Million
Q3 2023 Nov 13, 2023	SELL	$28.28 - $38.36 $559,944 - $759,528	-19,800 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$17.13 - $38.52 $1.08 Million - $2.43 Million	63,000 New	63,000 $1.44 Million
Q4 2022 Feb 14, 2023	BUY	$29.44 - $37.31 $1.36 Million - $1.73 Million	46,300 New	46,300 $1.58 Million
Q3 2022 Nov 13, 2023	BUY	$28.84 - $38.92 $571,032 - $770,616	19,800 New	19,800 $601,000

Others Institutions Holding SRDX

# of Institutions

144

Shares Held

12.5M

Call Options Held

103K

Put Options Held

212K

Black Rock Inc. New York, NY

1.17M
Shares

$44.4 Million
0.0% of portfolio
Alliancebernstein L.P. New York, NY

850K
Shares

$32.2 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

810K
Shares

$30.7 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

789K
Shares

$29.9 Million
1.82% of portfolio
Morgan Stanley New York, NY

656K
Shares

$24.9 Million
0.0% of portfolio

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $531M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account